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Cytokine Regulation during Epidermal
Differentiation and Barrier Formation
Atsunari Tsuchisaka1, Minao Furumura1 and Takashi Hashimoto1
The role of structural components and cell adhesion molecules in the epidermis
has not been fully studied in terms of the pathophysiology of atopic dermatitis
(AD). In this issue, Omori-Miyake et al. (2014) report that IL-4 and IL-13, which are
Th2 cytokines, downregulate the expression of keratins and desmosomal
cadherins in a STAT6-dependent manner, leading to keratinocyte fragility in the
face of mechanical stress. Th2 cytokine–induced instability of the epidermis may
be considered to be one of the pathogenic mechanisms that have roles in AD.
Journal of Investigative Dermatology (2014) 134, 1194–1196; doi:10.1038/jid.2014.15
The epidermis maintains its integrity and
stability primarily through the expres-
sion of cellular structural components
and adhesion molecules (Simpson et al.,
2011; Omori-Miyake et al., 2014). To
achieve terminal differentiation, the
epidermis undergoes keratinization,
whereas its keratinocytes move from
the stratum basale (basal layer) to the
stratum spinosum (spinal layer), stratum
granulosum (granular layer), and, as a
final product, the stratum corneum
(cornified layer; Figure 1, left panel;
Simpson et al., 2011).
The expression patterns of epidermal
keratins, profilaggrin/filaggrin, and des-
mosomal cadherins, i.e., desmogleins
1–4 (Dsg1–Dsg4) and desmocollins
1–3 (Dsc1–Dsc3), have been studied
extensively (Simpson et al., 2011;
Figure 1, left panel). Importantly, keratin
5 and keratin 14 are expressed at the
basal layer, whereas keratin 1 and ker-
atin 10 are expressed in suprabasal
layers. Profilaggrin is expressed in the
upper epidermis and it is processed into
filaggrin through proteolysis. With
respect to desmosomal cadherins,
Dsc1, Dsg1, and Dsg4 are expressed
strongly in the upper epidermis,
whereas Dsg2, Dsg3, Dsc2, and Dsc3
are expressed strongly in the lower
epidermis. Finally, corneodesmosin, a
component of corneodesmosome, is
expressed in the upper epidermis.
The component proteins of the tight
junction have been shown to be expre-
ssed in the epidermis by immunofluor-
escence analyses (Tunggal et al., 2005)
and they are now thought to have
important roles in skin barrier develop-
ment. Tight junction proteins were dete-
cted mainly at the boundary between
the granular and cornified layers; i.e.,
occludin and ZO-1 are found in the
granular layer, whereas claudin 1 is
expressed in the whole living epider-
mis (Figure 1, left panel).
Abnormalities in these structural com-
ponents and cell adhesion molecules
have been studied mainly in the heredi-
tary bullous and keratinizing diseases
and in the autoimmune bullous diseases.
Thus, it is now known that gene muta-
tions in keratin 5 or keratin 14 cause epi-
dermolysis bullosa hereditaria simplex,
whereas mutations in keratin 1 or keratin
10 cause epidermolytic ichthyosis (for-
merly, bullous congenital ichthyosiform
erythroderma). In addition, reduced
expression of filaggrin, by virtue of gene
mutations, is now known to cause
ichthyosis vulgaris and to facilitate the
development of atopic dermatitis (AD).
See related article on pg 1255 In contrast, cutaneous and mucosal
bullous lesions in the various types of
pemphigus are caused by pathogenic
autoantibodies directed against specific
desmosomal cadherins, i.e., Dsg1,
Dsg3, and Dsc1–Dsc3 (Hashimoto
et al., 2012). These autoantibodies
tend to produce histopathological
changes in the epidermis, precisely
where the targeted desmosomal cadhe-
rins are expressed. Thus, pemphigus
foliaceus and pemphigus vulgaris show
acantholytic changes in the upper and
lower portions of the epidermis,
respectively, where the target antigens,
Dsg1 and Dsg3, respectively, are expre-
ssed. In addition, subcorneal pustular
dermatosis type IgA pemphigus shows
an accumulation of neutrophils in the
uppermost epidermis, where the target
antigen, Dsc1, is expressed.
Terminal differentiation of the epider-
mis is achieved by several orchestrated
processes, namely, lipid production and
extrusion, formation of a filaggrin/kera-
tin network in the cytoplasm, formation
and disruption of desmosomes, and for-
mation of cornified envelopes, as well
as the formation of tight junctions in the
upper epidermis (Figure 1, right panel).
In the formation of the cornified envel-
ope, several precursor proteins are
expressed and bound to each other by
activated transglutaminase 1. Various
desmosomal cadherins and corneodes-
mosin function in keratinocyte cell
adhesion, and they are degraded
by proteolysis before desquamation.
Epidermal keratins and filaggrin form
the keratin network in the cornified
layer. Lipids are synthesized and extrude
outside corneocytes; tight junction
proteins are also expressed to form
the junctions. Coordination of these
processes is essential to the mainte-
nance of a stable epidermis.
Several earlier studies have examined
the role of cytokines in the regulation of
expression of structural components and
cell adhesion molecules, and on the
development of the epidermal barrier
during differentiation to a cornified
layer (Gutowska-Owsiak and Ogg,
2013; Ha¨nel et al., 2013; Figure 1, right
panel).
These studies have suggested that
most allergic inflammation-related cyto-
kines affect the expression of epidermal
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barrier–related proteins at multiple
levels. In particular, IL-4 and IL-13,
two major Th2 cytokines, suppress the
synthesis of proteins that are important
at different points in the differentiation
process (Figure 1, right panel. IL-4 and
IL-13 are highlighted by red-colored
letters, because they are studied by
Omori-Miyake et al. (2014) in this
issue of JID.).
Thus, keratinocyte differentiation pro-
cesses are highly regulated by these
cytokines. This leads to the concept that
abnormal expression of cytokines in the
skin, which is evident in AD, may
disrupt the skin barrier. Moreover,
cytokines were reported to change the
synthesis and localization of the tight
junction proteins in previous studies
(Capaldo and Nusrat, 2009; Figure 1,
right panel).
Until recently, AD was thought to
develop through immunological
mechanisms, particularly through the
activities of Th2 cells, which produce a
number of Th2 cytokines, including IL-
4, IL-5, IL-6, IL-10, IL-13, and GM-CSF
(Brandt and Sivaprasad, 2011; Leung,
2013). Among the Th2 cytokines, IL-4
and IL-13 have been studied most
extensively (Brandt and Sivaprasad,
2011). In particular, the signal transduc-
tion study downstream of IL-4 binding of
type I IL-4 receptor and IL-13 binding to
type II IL-4 receptor/IL-13 receptor
revealed the importance of activated
Jak kinase followed by the activation
of STAT6.
However, more recently, mutations in
the filaggrin gene have been identified
in AD patients at significantly high rates,
suggesting an important role for the
disruption of the skin barrier in AD
(Leung, 2013). At about the same time,
tight junctions were proven to be pre-
sent in the epidermis (Tunggal et al.,
2005; Kim and Leung, 2012) and to
function in the activation of immuno-
logical cells, including Langerhans cells.
This has suggested that abnormal tight
junction function might also be related
to AD development.
In contrast, the role of structural
components and cell adhesion mole-
cules, which are important for maintain-
ing epidermal stability and integrity, in
the development of AD has not been
fully examined. In this issue of JID,
Omori-Miyake et al. (2014) report that
IL-4 and IL-13, which regulate STAT6
Clinical Implications
 IL-4 and IL-13, which are Th2 cytokines, downregulate the expression of
keratins, filaggrin, and desmosomal cadherins, as well as tight junction
components, via an IL-4 receptor-alpha- and STAT6-dependent mechanism.
 The suppression of these proteins leads to fragmentation of cultured
keratinocytes through mechanical stress.
 Th2 cytokine–induced instability of the epidermis may have a role in the
pathogenesis of atopic dermatitis.
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Figure 1. Schematic diagram of four layers of the epidermis, expression profiles of keratins, filaggrin, and desmosomal and tight junction proteins, five
terminal differentiation processes, and regulation by cytokines. Left panel shows four distinct epidermal layers and expression patterns of four keratins,
filaggrin, four Dsgs, three Dscs, corneodesmosin, and tight junction proteins. Right panel shows detailed information for five distinct epidermal differentiation
processes, as well as various cytokines, which upregulate or downregulate the epidermal differentiation. IL-4 and IL-13 are shown in red-colored letters.
The left panel was adapted from the figure in the reference of Simpson et al. (2011), and the right panel was adapted from figures in the reference of Ha¨nel et al.
(2013) and Gutowska-Owsiak and Ogg (2013).
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and p44/42MAPK signaling, suppress the
expression of structural compo-
nents and cell adhesion molecules in
murine and human keratinocyte cultures.
Omori-Miyake et al. (2014) first
observed that IL-4 would suppress the
expression of Dsg1, Dsc1, keratin 1, and
keratin 10 at both mRNA and
protein levels in murine and human
cultured keratinocytes. The authors
confirmed that the regulation by IL-4
was dependent on IL-4 receptor-alpha
and STAT6.
Moreover, the suppression of expres-
sion of Dsg1, keratin 1, and keratin 10 by
IL-4 was prevented by the addition of an
MEK inhibitor, suggesting that the sup-
pression was regulated via p44/42MAPK
signaling. Addition of the p38MAPK inhi-
bitor did not alter the suppressed expres-
sion of Dsg1, keratin 1, or keratin 10 by
IL-4, suggesting that p38MAPK is not
responsible in this suppression. The sup-
pression of Dsc1 expression by IL-4 was
not prevented by the addition of the MEK
inhibitor, suggesting the important role of
STAT6 signaling in Dsc1 expression.
Similar suppressive effects were also
found by the addition of IL-13 in parallel
experiments. In contrast, the addition of
IL-5 did not cause a suppressive effect.
These results suggest that IL-4 and
IL-13 have important roles in the patho-
genesis of AD.
Omori-Miyake et al. (2014) also
examined mRNA expression levels of
keratins and desmosomal components
in IL-4 receptor-alpha chain–deficient
keratinocytes. No reduction in mRNA
expression for these proteins was
observed by the addition of IL-4 and
IL-13 in these deficient keratinocytes,
confirming that IL-4 and IL-13 exerted
their effects via the IL-4 receptor-
alpha chain.
Finally, the addition of IL-4 and IL-13
to cultured HaCaT cells led to cell
fragmentation through downregulation
of expression of Dsg1, Dsc1, keratin 1,
and keratin 10. The authors speculated
that AD may develop or be exacerbated
by the disruption of epidermal stability
owing to the suppression of structural
components and cell adhesion mole-
cules by Th2 cytokines.
This work is the first comprehensive
study of the role of Th2 cytokines on the
suppression of structural components
and cell adhesion molecules, leading
to reduced stability and integrity of
keratinocytes. It indicates that in addi-
tion to immunological and allergic
mechanisms, as well as filaggrin muta-
tion and tight junction–related changes
in the skin barrier, the stability and
integrity of the epidermis itself, which
are regulated by cytokines, may also
have important roles in AD.
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Dormant Melanomas or Changing
Nevi?
Giuseppe Argenziano1, Aimilios Lallas1, Caterina Longo1,
Elvira Moscarella1, Margherita Raucci1 and Iris Zalaudek1,2
The development of new primary melanomas in patients treated with
vemurafenib has been reported recently in a study by Perier-Muzet et al. The
primary outcome of the study was to describe the dermoscopic changes that
prompted excision of those melanomas. However, the crucial point raised by the
study is the large number of melanomas that were detected.
Journal of Investigative Dermatology (2014) 134, 1196–1198; doi:10.1038/jid.2013.512
The study by Perier-Muzet et al. (2014)
is an important contribution, one that
reports the largest series of second
primary melanomas in patients treated
with vemurafenib for advanced melano-
mas. The development of multiple
See related article on pg 1351
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